Sign in Sign up for free

Last updated: 1 October 2019 at 6:46pm EST

Bernard Tobin Net Worth




The estimated Net Worth of Bernard Tobin is at least $7.04 Million dollars as of 1 August 2019. Mr. Tobin owns over 11,712 units of Myriad Genetics stock worth over $3,837,931 and over the last 10 years he sold MYGN stock worth over $468,480. In addition, he makes $2,734,520 as President - Myriad Autoimmune at Myriad Genetics.

Mr. Tobin MYGN stock SEC Form 4 insiders trading

Bernard has made over 1 trades of the Myriad Genetics stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 11,712 units of MYGN stock worth $468,480 on 1 August 2019.

The largest trade he's ever made was selling 11,712 units of Myriad Genetics stock on 1 August 2019 worth over $468,480. On average, Bernard trades about 781 units every 0 days since 2015. As of 1 August 2019 he still owns at least 146,040 units of Myriad Genetics stock.

You can see the complete history of Mr. Tobin stock trades at the bottom of the page.





Bernard Tobin biography

Bernard Francis Tobin is the President - Myriad Autoimmune a wholly owned subsidiary of the Company. He previously held several senior positions at Amgen over the course of 8 years, including Executive Director of National Accounts, General Manager of both the Netherlands and Brazil, and Global Head of Commercial Excellence. In addition, he led the global integration of business development acquisition in more than 100 countries. Prior to that, Mr. Tobin held a variety of leadership roles in the commercial organization at Eli Lilly and Co. over the course of 16 years. He received his B.S. degree in public service and administration from Iowa State University and his M.B.A from the Fuqua School of Business, Duke University.

What is the salary of Bernard Tobin?

As the President - Myriad Autoimmune of Myriad Genetics, the total compensation of Bernard Tobin at Myriad Genetics is $2,734,520. There are 1 executives at Myriad Genetics getting paid more, with R. Bryan Riggsbee having the highest compensation of $3,138,980.



How old is Bernard Tobin?

Bernard Tobin is 56, he's been the President - Myriad Autoimmune of Myriad Genetics since 2015. There are 16 older and 10 younger executives at Myriad Genetics. The oldest executive at Myriad Genetics, Inc. is Walter Gilbert, 87, who is the Independent Vice Chairman of the Board.

What's Bernard Tobin's mailing address?

Bernard's mailing address filed with the SEC is 320, Wakara Way, U of U Research Park, Salt Lake City, Salt Lake County, Utah, 84108, United States.

Insiders trading at Myriad Genetics

Over the last 22 years, insiders at Myriad Genetics have traded over $51,783,466 worth of Myriad Genetics stock and bought 61,160 units worth $1,252,955 . The most active insiders traders include Jerry S Lanchbury, Peter D Meldrum, and Arthur H Jr Hayes. On average, Myriad Genetics executives and independent directors trade stock every 18 days with the average trade being worth of $563,312. The most recent stock trade was executed by Heinrich Dreismann on 9 September 2024, trading 10,000 units of MYGN stock currently worth $270,500.



What does Myriad Genetics do?

myriad genetics inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. myriad is focused on three strategic imperatives: maintaining leadership in an expanding hereditary cancer market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. for more information on how myriad is making a difference, please visit the company's website: www.myriad.com.



What does Myriad Genetics's logo look like?

Myriad Genetics, Inc. logo

Complete history of Mr. Tobin stock trades at Myriad Genetics

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
1 Aug 2019 MYGN Myriad Genetics, Inc. Bernard Tobin
President Crescendo BioScience
 Sale 11,712 $40.00 $468,480
1 Aug 2019
146,040 ↗


Myriad Genetics executives and stock owners

Myriad Genetics executives and other stock owners filed with the SEC include: